Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC

Shaping the Management of Multiple Sclerosis " The Potential for BTK Inhibitors in Clinical Practice

Access Activity

Overview / Abstract:

Activity Overview
Advances in the understanding of immune mechanisms that contribute to the pathophysiology of multiple sclerosis (MS) have led to the development of many disease-modifying therapies that target effector T cells, regulatory cells, B cells, and cell trafficking into the nervous system. Among these emerging pathways is use of Bruton tyrosine kinase (BTK) inhibitors, which block the actions of B cells and may affect other cell types that can facilitate inflammation. This bridging of adaptive and innate immunity separates BTK inhibition from other currently available B-cell targeting therapies, such as depletion by CD20 antibodies.
This continuing education satellite symposium program, presented at the 2022 International Congress on the Future of Neurology®, aims to update clinicians on key clinical data pertaining to current and emerging B-cell"depleting and BTK-inhibiting therapies for the treatment of patients with MS. Clinicians also can expect to learn about approaches to personalizing care.
Target Audience
This educational activity is directed toward neurologists, nurse practitioners, physician assistants, and other health care professionals involved in the diagnosis and management of patients with MS.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
• Review the role of Bruton’s tyrosine kinase (BTK) in the pathogenesis of multiple sclerosis (MS)
• Analyze clinical trial data for BTK inhibitors in the treatment of MS
• Develop individualized treatment plans for patients with MS

Expiration

Oct 12, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Stephen Krieger, MD, FAAN
Erin Longbrake, MD, PhD

Sponsors / Supporters / Grant Providers

Sanofi

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, BTK Inhibitors Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map